On May 11, 2021, the ITC issued a Notice of Investigation in Certain High-Potency Sweeteners, Processes for Making Same, and Products Containing Same (Inv. No. 337-TA-1264).

On January 5, 2022, the Commission a notice of its final determination of a violation of section 337 and issuance of a general exclusion order in Certain Vacuum Insulated Flasks and Components Thereof.

JTEKT's petition for certiorari frames the issue as whether Congress conferred standing to IPR petitioners through the IPR statutory scheme.

Three years after a previous legal battle between Sequenom and Ariosa ended in a difficult loss for Sequenom (in what some commentators have characterized as a misapplication ...

On June 23, 2022, the FDA banned the sale of Juul's tobacco-and menthol-flavored products. The agency's reasoning was that Juul's applications did not have sufficient toxicological...

Now is a time of great uncertainty for all of us as the COVID-19 pandemic has affected many of us personally and professionally. Most Intellectual Property Offices around the world have taken...

On April 29, 2022, Precision Holdings USA Inc. of Rocklin, California and Innovamed Health LLC of San Antonio, Texas (collectively, "Complainants") filed a complaint requesting that the ITC commence...

In Bausch Health Ireland v. Mylan Pharms. N.D. WV., 1:22CV20 Bausch moved for judgment of infringement on the pleadings under Rule 12(c) to prevent Mylan's...

The Globalization of U.S. Patent Law: May Risk Infringement Even Without Significant U.S. Presence.

The U.S. Patent and Trademark Office (USPTO) has issued an update to the guidance on patent subject matter eligibility to address artificial intelligence

The five largest intellectual property offices in the world (IP5) launched this pilot on July 1, 2018.

The USPTO recently identified several decisions as informative. While not binding, an informative decision provides guidance for patent applicants, examiners and the PTAB.

Oblon has already undertaken efforts to protect its employees and guests as well as certain pro-active steps to provide continuing, uninterrupted service to our clients.

The uncertainty surrounding the patentability of biologics has led the industry to search for potential alternatives to patent protection.

On May 5, 2022, ALJ MaryJoan McNamara issued the public version (Part I, Part II) of her April 7, 2022 initial determination ("ID")...

On December 6, 2021, Chief ALJ Charles E. Bullock issued a notice of his initial determination ("ID") finding a violation of section 337...

In the recent AIDS Healthcare Foundation v. Gilead opinion, the Federal Circuit considered whether AHF's desire to "‘clear out the invalid patents' so that it ‘would have the ability ...

Further to our February 5, 2021 post, the Commission issued the public version of its opinion on remedy, public interest, and bonding in Certain Foldable Reusable Drinking Straws and...

Drafting claims with infringement in mind has always been a challenge. For instance, claims should be drafted to ensure that they can be infringed by a single party in order to address divided infringement issues.

In Pfizer Inc. vs. Sanofi Pasteur Inc., the Federal Circuit upheld the Patent Trial and Appeal Board (PTAB) decision to invalidate portions of Pfizer's pneumococcal...